JP2016067710A - Medical treatment instrument and medical system - Google Patents

Medical treatment instrument and medical system Download PDF

Info

Publication number
JP2016067710A
JP2016067710A JP2014201829A JP2014201829A JP2016067710A JP 2016067710 A JP2016067710 A JP 2016067710A JP 2014201829 A JP2014201829 A JP 2014201829A JP 2014201829 A JP2014201829 A JP 2014201829A JP 2016067710 A JP2016067710 A JP 2016067710A
Authority
JP
Japan
Prior art keywords
tubular member
main body
medical
end side
distal end
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014201829A
Other languages
Japanese (ja)
Inventor
リヤー アラスト
Riyah Arastoo
リヤー アラスト
広介 西尾
Kosuke Nishio
広介 西尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP2014201829A priority Critical patent/JP2016067710A/en
Publication of JP2016067710A publication Critical patent/JP2016067710A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide a medical treatment instrument which performs hemostasis of a treatment part and can easily place a medical material providing an epithelial function on the treatment part.SOLUTION: A medical treatment instrument comprises: a body part 110 which is inserted into a urinary tract 10, can extend and contract in a Y direction in the urinary tract 10, and forms a plurality of layers in a circumferential direction in a contracted state; an extension part 111A which is provided on an innermost layer of the body part, extends the body part while moving to a tip side by being pushed out, and can maintain the position of the body part in the urinary tract in an extended state; and a movable part 113C which is provided on an outermost layer of the body part in a state in which a medical material can be disposed on an outer periphery 113D, and contracts the body part while moving along the extension part.SELECTED DRAWING: Figure 4

Description

本発明は、医療用処置具及び医療システムに関する。   The present invention relates to a medical treatment tool and a medical system.

生体の体腔内が狭窄する症状として、例えば、尿道狭窄症が挙げられる。尿道狭窄症とは、怪我や炎症により尿道粘膜に傷がついて、その傷が修復される過程で尿道粘膜や尿道粘膜を取り囲む尿道海綿体に瘢痕化が起こり、瘢痕組織によって尿道が狭くなる疾患である。尿道狭窄症の治療方法として、外科的に尿道を再建する治療法が存在する。この治療法では尿道狭窄症の再発を防止するために、口腔粘膜を尿道内壁の処置部に直接縫合することによって移植が行われるが、患者にとっては侵襲度が高く、長期の入院が必要となる。   Examples of the stenosis in the body cavity of a living body include urethral stricture. Urethral stricture is a disease in which the urethral mucosa is damaged by injury or inflammation, and scarring occurs in the urethral mucosa and the urethral cavernosa surrounding the urethral mucosa in the process of repairing the wound, and the urethra is narrowed by scar tissue. is there. As a treatment method for urethral stricture, there is a treatment method for surgically reconstructing the urethra. In this therapy, in order to prevent recurrence of urethral stricture, transplantation is performed by directly stitching the oral mucosa to the treatment part of the inner wall of the urethra, but the patient is highly invasive and requires long-term hospitalization. .

これに対して、尿道狭窄症の狭窄部を処置するための、経尿道的に挿入されるバルーンカテーテルがある。このバルーンカテーテルでは、バルーンの周囲にステントが配置されており、狭窄部でバルーンとともにステントが拡張されることで、前立腺肥大の症状を緩和することが説明されている(特許文献1を参照)。   On the other hand, there is a balloon catheter inserted transurethrally for treating a stenosis portion of urethral stricture. In this balloon catheter, a stent is disposed around the balloon, and it is described that the stent is expanded together with the balloon in a stenosis portion to alleviate the symptoms of prostatic hypertrophy (see Patent Document 1).

特開昭63−214264号公報JP 63-214264 A

しかしながら、デバイスを狭窄部に配置する際、狭窄の度合いによっては前処置によってデバイスが挿入できるだけの空間を作成する必要がある。この前処置では、尿道切開刀のような処置デバイスが使用されるが、この処置では出血が生じることがある。その場合、術者は出血を止血するためにデバイスを処置部まで導入し、圧迫止血を行う必要がある。   However, when placing the device in the stenosis, it is necessary to create a space that allows the device to be inserted by pretreatment depending on the degree of stenosis. This pre-treatment uses a treatment device such as a urethrectomy, which may cause bleeding. In that case, it is necessary for the surgeon to introduce the device to the treatment site and stop the bleeding by stopping the bleeding.

本発明は、上記の課題を解決するためになされたものであり、処置部の止血を行うとともに、上皮機能を提供する医療材料を、容易に処置部に留置することのできる医療用処置具及び医療システムを提供することを目的とする。   The present invention has been made in order to solve the above-described problems, and provides a medical treatment instrument that can stop a hemorrhage of a treatment part and can easily place a medical material that provides an epithelial function in the treatment part. The purpose is to provide a medical system.

上記目的は、下記(1)〜(9)に記載のいずれかの発明により達成される。   The object is achieved by any one of the inventions described in (1) to (9) below.

(1)生体の体腔内に上皮機能を提供する医療材料を配置するための医療用処置具であって、前記体腔内に挿通され、当該体腔内の長軸方向に伸縮可能とし、収縮状態において周方向に複数の層をなす本体部と、前記本体部の最内層に設けられ、押出されることにより挿通方向の先端側に移動して前記本体部を伸長させるとともに、伸長状態において前記本体部の前記体腔内における位置を維持可能とする伸長部と、外周に前記医療材料を配置可能な状態で前記本体部の最外層に設けられ、前記伸長部に沿って移動し前記本体部を収縮させる移動部と、を有する医療用処置具。   (1) A medical treatment tool for placing a medical material that provides an epithelial function in a body cavity of a living body, which is inserted into the body cavity and can be expanded and contracted in the longitudinal direction of the body cavity, and in a contracted state A main body portion that forms a plurality of layers in the circumferential direction, and is provided in the innermost layer of the main body portion, and is moved to the distal end side in the insertion direction by being pushed out to extend the main body portion, and in the extended state, the main body portion An extension portion that can maintain the position in the body cavity and an outermost layer of the main body portion in a state where the medical material can be disposed on the outer periphery, and moves along the extension portion to contract the main body portion A medical treatment instrument having a moving part.

(2)前記本体部は、入れ子構造をなす複数の管状部材からなり、前記伸長部は、複数の前記管状部材のうち最内周に位置する最内周管状部材に設けられ、前記管状部材を前記先端側に押し出す第1押出部材により押されて前記本体部を伸長させ、前記移動部は、複数の前記管状部材のうち最外周に位置する最外周管状部材に設けられ、前記管状部材を前記先端側に押し出す第2押出部材により押されて前記本体部を収縮させる上記(1)に記載の医療用処置具。   (2) The main body portion is composed of a plurality of tubular members having a nested structure, and the extending portion is provided on an innermost peripheral tubular member located on the innermost periphery among the plurality of tubular members, The main body portion is extended by being pushed by the first push-out member pushed out to the distal end side, and the moving portion is provided on an outermost peripheral tubular member located at an outermost periphery among the plurality of tubular members, and the tubular member is The medical treatment tool according to (1), wherein the main body portion is contracted by being pushed by a second push-out member pushed toward the distal end side.

(3)前記伸長部は、前記第1押出部材の先端部に突き当てられることによって押されて、前記本体部を伸長させる上記(2)に記載の医療用処置具。   (3) The medical treatment instrument according to (2), wherein the extending portion is pushed by being abutted against a distal end portion of the first pushing member to extend the main body portion.

(4)前記伸長部は、前記第1押出部材と互いに係合する係合部を有する上記(2)または(3)に記載の医療用処置具。   (4) The medical treatment instrument according to (2) or (3), wherein the extending portion includes an engaging portion that engages with the first push member.

(5)前記伸長部は、前記最内層の内部に設けられ拡張変形可能な拡張部を有する上記(1)〜(4)のいずれか1つに記載の医療用処置具。   (5) The medical treatment instrument according to any one of (1) to (4), wherein the extension portion includes an extension portion that is provided inside the innermost layer and can be expanded and deformed.

(6)前記移動部が、前記本体部を収縮させる際に、前記最内層が前記先端側に移動することを規制する規制部をさらに有する上記(1)〜(5)のいずれか1つに記載の医療用処置具。   (6) In any one of the above (1) to (5), the moving portion further includes a restricting portion that restricts movement of the innermost layer toward the tip side when the main body portion contracts. The medical treatment instrument described.

(7)前記医療材料は、生体シートであって、前記体腔は、尿道に形成された狭窄部である上記(1)〜(6)のいずれか1つに記載の医療用処置具。   (7) The medical treatment tool according to any one of (1) to (6), wherein the medical material is a biological sheet, and the body cavity is a stenosis portion formed in the urethra.

(8)上記(1)〜(7)のいずれか1つに記載の医療用処置具と、前記伸長部を前記先端側に押し出す第1押出部材と、前記移動部を前記先端側に押し出す第2押出部材と、を有する医療システム。   (8) The medical treatment instrument according to any one of (1) to (7), a first push-out member that pushes the extending portion toward the distal end side, and a first pusher that pushes the moving portion toward the distal end side. A medical system having two extrusion members.

(9)前記第1押出部材は、内視鏡を有する上記(8)に記載の医療システム。   (9) The medical system according to (8), wherein the first push member includes an endoscope.

上記(1)に記載の発明によれば、上皮機能を提供する医療材料を尿道入口から処置部まで導入する際に、まず、伸長部が押出されることにより挿通方向の先端側に移動して本体部を伸長させ、本体部の最内層を処置部まで導入する。その後、移動部が伸長部に沿って移動して本体部を収縮させる。この一連の作業によって、上皮機能を提供する医療材料を処置部に留置させることができる。したがって、この医療用処置具によれば、上皮機能を提供する医療材料を処置部に所定期間留置する際に、処置部の止血を行った状態で、上皮機能を提供する医療材料を、容易に処置部に留置することのできる医療用処置具を提供することができる。   According to the invention described in (1) above, when a medical material that provides epithelial function is introduced from the urethral entrance to the treatment portion, first, the extension portion is pushed to move to the distal end side in the insertion direction. The main body is extended and the innermost layer of the main body is introduced to the treatment section. Thereafter, the moving part moves along the extending part to contract the main body part. Through this series of operations, the medical material that provides the epithelial function can be placed in the treatment section. Therefore, according to this medical treatment instrument, when the medical material that provides the epithelial function is placed in the treatment portion for a predetermined period, the medical material that provides the epithelial function can be easily obtained in a state in which the treatment portion is hemostatic. A medical treatment instrument that can be placed in the treatment section can be provided.

上記(2)に記載の発明によれば、上皮機能を提供する医療材料を尿道入口から処置部まで導入する際に、まず、伸長部が第1押出部材により押されることによって、入れ子状態の管状部材を挿入方向の先端側に押し出して、最内周管状部材が処置部まで導入されるように、複数の管状部材からなる本体部を軸線方向に伸長させる。その後、移動部が第2押出部材により押されることによって、伸長状態の管状部材を先端側に押し出して本体部を収縮させ入れ子状態とする。この一連の作業によって、上皮機能を提供する医療材料を処置部に留置させることができる。したがって、この医療用処置具によれば、上皮機能を提供する医療材料を処置部に所定期間留置する際に、処置部の止血を行った状態で、上皮機能を提供する医療材料を、容易に処置部に留置することのできる医療用処置具を提供することができる。   According to the invention described in (2) above, when the medical material providing the epithelial function is introduced from the urethral entrance to the treatment portion, first, the elongated portion is pushed by the first push member, so that the nested tubular shape is obtained. The member is pushed out to the distal end side in the insertion direction, and the main body portion made of a plurality of tubular members is extended in the axial direction so that the innermost peripheral tubular member is introduced to the treatment portion. Thereafter, when the moving part is pushed by the second push-out member, the expanded tubular member is pushed out to the distal end side, and the main body part is contracted to be in a nested state. Through this series of operations, the medical material that provides the epithelial function can be placed in the treatment section. Therefore, according to this medical treatment instrument, when the medical material that provides the epithelial function is placed in the treatment portion for a predetermined period, the medical material that provides the epithelial function can be easily obtained in a state in which the treatment portion is hemostatic. A medical treatment instrument that can be placed in the treatment section can be provided.

上記(3)に記載の発明によれば、容易な動作によって、伸長部が第1押出部材に押されるため、手技が容易となる。   According to the invention described in (3) above, since the extension portion is pushed by the first push member by an easy operation, the procedure becomes easy.

上記(4)に記載の発明によれば、係合部によって伸長部が第1押出部材に係合されるため、第1押出部材がより確実に最内層を押すことができる。   According to the invention as described in said (4), since an expansion | extension part is engaged with a 1st extrusion member by an engaging part, a 1st extrusion member can push an innermost layer more reliably.

上記(5)に記載の発明によれば、拡張部によって伸長部が第1押出部材に接続されるため、第1押出部材がより確実に最内層を押すことができる。   According to the invention as described in said (5), since the expansion | extension part is connected to the 1st extrusion member by the expansion part, the 1st extrusion member can push an innermost layer more reliably.

上記(6)に記載の発明によれば、本体部を収縮させる際に、規制部は最内層が先端側に移動することを規制するため、より確実に最内層を処置部に配置することができる。   According to the invention described in (6) above, when the main body portion is contracted, the restricting portion restricts the innermost layer from moving toward the distal end side, so that the innermost layer can be more reliably disposed in the treatment portion. it can.

上記(7)に記載の発明によれば、尿道狭窄症に対応した医療用処置具を提供することができる。   According to the invention as described in said (7), the medical treatment tool corresponding to urethral stricture can be provided.

上記(8)に記載の発明によれば、上述の医療用処置具を有するため、処置部の止血を行った状態で、上皮機能を提供する医療材料を、容易に処置部に留置することのできる医療システムを提供することができる。   According to the invention described in the above (8), since the medical treatment tool is provided, a medical material that provides an epithelial function can be easily placed in the treatment portion in a state where the treatment portion is hemostatic. A medical system that can be provided can be provided.

上記(9)に記載の発明によれば、内視鏡で体腔内を観察しつつ、上皮機能を提供する医療材料を処置部に留置することできるため、手技が容易となる。   According to the invention described in (9) above, the medical material that provides the epithelial function can be placed in the treatment portion while observing the inside of the body cavity with an endoscope, so that the procedure is facilitated.

図1は、生体の尿道を示す図であって、図1(A)は、生体の尿道周辺を模式的に示す図、図1(B)は、図1(A)に示す1B−1B線に沿う尿道の断面図である。1A and 1B are diagrams showing a urethra of a living body, in which FIG. 1A is a diagram schematically showing the periphery of the urethra of a living body, and FIG. 1B is a line 1B-1B shown in FIG. It is sectional drawing of the urethra along. 図1に示す尿道及びその周辺部の断面図であって、図1(A)に示す2A−2A線(尿道の延伸方向に沿う線)に沿う断面図である。It is sectional drawing of the urethra shown in FIG. 1, and its peripheral part, Comprising: It is sectional drawing which follows the 2A-2A line | wire (line in alignment with the extending direction of a urethra) shown to FIG. 1 (A). 図3は、尿道及び尿道海綿体を拡大して示す図であって、図3(A)は、図1(B)に示す尿道周辺を拡大した断面図、図3(B)は、図3(A)に示す破線部3Bを拡大した断面図である。3 is an enlarged view of the urethra and the urethral cavernous body, in which FIG. 3A is an enlarged cross-sectional view around the urethra shown in FIG. 1B, and FIG. 3B is FIG. It is sectional drawing to which the broken-line part 3B shown to (A) was expanded. 図4は、本発明の実施形態に係る医療システムを示す斜視図であって、図4(A)は、本体部が収縮して入れ子状態となっている状態を示し、図4(B)は、本体部が伸長している状態を示す。FIG. 4 is a perspective view showing a medical system according to an embodiment of the present invention. FIG. 4A shows a state in which the main body portion is contracted and is nested, and FIG. The state which the main-body part is extending | stretched is shown. 伸長状態の本体部を示す正面断面図である。It is front sectional drawing which shows the main-body part of an expansion | extension state. 医療用処置具を尿道の入口から挿入した様子を示す図である。It is a figure which shows a mode that the medical treatment tool was inserted from the entrance of the urethra. 第1押出部材を第1管状部材の内部に挿入する前の様子を示す図である。It is a figure which shows the mode before inserting a 1st extrusion member in the inside of a 1st tubular member. 第1押出部材が伸長部を先端側に押して、第1管状部材が処置部まで押し出された様子を示す図である。It is a figure which shows a mode that the 1st extrusion member pushed the expansion | extension part to the front end side, and the 1st tubular member was extruded to the treatment part. 第2押出部材が移動部を先端側に押して、第3管状部材が処置部まで押し出された様子を示す図である。It is a figure which shows a mode that the 2nd extrusion member pushed the moving part to the front end side, and the 3rd tubular member was extruded to the treatment part. 第1押出部材を第1管状部材の内部から抜去した後の様子を示す図である。It is a figure which shows a mode after extracting the 1st extrusion member from the inside of a 1st tubular member. 改変例1に係る医療用処置具の第1管状部材の先端部における側面断面図である。It is side surface sectional drawing in the front-end | tip part of the 1st tubular member of the medical treatment tool which concerns on the modification 1. 改変例2に係る医療システムの第1管状部材及び第1押出部材を示す概略図である。It is the schematic which shows the 1st tubular member and 1st extrusion member of the medical system which concerns on the modification 2. 改変例3に係る医療システムの第1管状部材及び第1押出部材を示す概略図である。It is the schematic which shows the 1st tubular member and 1st extrusion member of the medical system which concerns on the modification 3. 改変例4に係る医療システムの第1管状部材及び第1押出部材を示す概略図である。It is the schematic which shows the 1st tubular member and 1st extrusion member of the medical system which concerns on the modification 4. 改変例5に係る医療システムの第1管状部材及び第1押出部材を示す正面断面図である。It is front sectional drawing which shows the 1st tubular member and 1st extrusion member of the medical system which concerns on the modification 5. 改変例5に係る医療システムの第1管状部材及び第1押出部材を示す正面断面図である。It is front sectional drawing which shows the 1st tubular member and 1st extrusion member of the medical system which concerns on the modification 5. 改変例6に係る医療システムの第1管状部材の先端部における側面断面図であって、図17(A)は、第1管状部材及び第1押出部材が接続されている様子を示し、図17(B)は、第1管状部材及び第1押出部材の接続状態が解除された様子を示す図である。It is side surface sectional drawing in the front-end | tip part of the 1st tubular member of the medical system which concerns on the modification 6, Comprising: FIG. 17 (A) shows a mode that the 1st tubular member and the 1st extrusion member are connected, FIG. (B) is a figure which shows a mode that the connection state of the 1st tubular member and the 1st extrusion member was cancelled | released. 改変例7に係る医療システムの第1押出部材の構成を説明するための図である。It is a figure for demonstrating the structure of the 1st extrusion member of the medical system which concerns on the modification 7. FIG.

以下、図面を参照して、本発明の実施形態を説明する。なお、図面の寸法比率は、説明の都合上、誇張されて実際の比率とは異なる場合がある。また、以下の説明において、本実施形態に係る医療システム1の手元操作側を「基端側」、尿道10内へ挿入される側を「先端側」と称する。   Hereinafter, embodiments of the present invention will be described with reference to the drawings. In addition, the dimension ratio of drawing is exaggerated on account of description, and may differ from an actual ratio. Further, in the following description, the hand operation side of the medical system 1 according to the present embodiment is referred to as “base end side”, and the side inserted into the urethra 10 is referred to as “distal end side”.

図1〜図3は、尿道狭窄症に罹患した生体の尿道を模式的に示す図、図4〜図5は、本実施形態に係る医療システム1を示す図、図6〜図10は、本実施形態に係る医療システム1を用いた手技を説明するための図である。   1 to 3 are diagrams schematically showing a urethra of a living body suffering from urethral stricture, FIGS. 4 to 5 are diagrams showing a medical system 1 according to the present embodiment, and FIGS. It is a figure for demonstrating the procedure using the medical system 1 which concerns on embodiment.

ここでは、治療部位の一例として、尿道に形成された狭窄部を例に挙げて説明する。本実施形態に係る医療システム1は、尿道に形成された狭窄部を施術した後に再狭窄(再閉塞)が生じることを抑制するためのシステムである。まず、生体の尿道周辺の構造、尿道狭窄症、及び再狭窄の発生メカニズムについて説明する。   Here, a stenosis portion formed in the urethra will be described as an example of a treatment site. The medical system 1 according to the present embodiment is a system for suppressing the occurrence of restenosis (re-occlusion) after performing a stenosis portion formed in the urethra. First, the structure around the urethra of the living body, the urethral stricture, and the occurrence mechanism of restenosis will be described.

図1〜図3には、男性の尿道10及びその周辺部が模式的に示されている。尿道10は、図1(A)に示すように、陰茎21の内部及び前立腺22の内部を通って生体の下腹部にある膀胱23まで延びている。また、尿道10は、図1(B)、図3(A)に示すように、その内面11が尿道粘膜12により覆われている。尿道粘膜12の外側には尿道海綿体13が存在する。また、図3(B)に示すように、尿道海綿体13の内部には網目状に走行する海綿体洞と呼ばれる血管14が存在する。なお、各図に付されたX軸は尿道の幅方向(図1(B)の左右方向)を示し、Y軸は尿道の延伸方向(図2の上下方向)を示し、Z軸は尿道の高さ方向(図1(B)の上下方向)を示している。   1 to 3 schematically show a male urethra 10 and its peripheral portion. As shown in FIG. 1A, the urethra 10 extends through the penis 21 and the prostate 22 to the bladder 23 in the lower abdomen of the living body. In addition, as shown in FIGS. 1B and 3A, the inner surface 11 of the urethra 10 is covered with the urethral mucosa 12. A urethral cavernous body 13 is present outside the urethral mucosa 12. In addition, as shown in FIG. 3B, a blood vessel 14 called a cavernous sinus that runs in a mesh form exists inside the urethral cavernous body 13. In addition, the X-axis attached | subjected to each figure shows the width direction (left-right direction of FIG. 1 (B)) of a urethra, the Y-axis shows the extending | stretching direction (up-down direction of FIG. 2) of a urethra, and Z-axis shows the urethra. The height direction (the vertical direction in FIG. 1B) is shown.

図1(B)に示すように、尿道海綿体13は、白膜24により覆われており、この白膜24の外側には筋膜25及び陰茎海綿体26が存在する。陰茎海綿体26の内部には陰茎深動脈26aが存在し、陰茎海綿体26の上方には陰茎背動脈26b及び陰茎背静脈26cが存在する。   As shown in FIG. 1B, the urethral cavernous body 13 is covered with a white membrane 24, and the fascia 25 and the penile cavernous body 26 exist outside the white membrane 24. A penile deep artery 26 a exists inside the penile cavernous body 26, and a penile dorsal artery 26 b and a penile dorsal vein 26 c exist above the penile cavernous body 26.

尿道狭窄症は、例えば、外傷や炎症によって尿道粘膜12もしくは尿道海綿体13が損傷した後、修復される過程で尿道粘膜12や尿道粘膜12を取り囲む尿道海綿体13に組織の繊維化及び瘢痕化が生じて、図2に示すように尿道内面11に瘢痕組織31が形成され、その結果、尿道10の内腔が狭くなる疾患である。尿道10において瘢痕組織31が形成された部位(狭窄部30)は、尿道10の他の部位に比べて断面積が狭くなるため、尿が通過し難くなる。尿道狭窄症に罹患すると、尿が円滑に排出されない、尿が全く排出されないといった排尿障害が引き起こされる。   In the urethral stricture, for example, the urethral mucosa 12 or the urethral cavernous body 13 is damaged by trauma or inflammation, and then repaired, and the tissue is fibrillated and scarred in the urethral cavernous body 13 surrounding the urethral mucosa 12. As shown in FIG. 2, a scar tissue 31 is formed on the inner surface 11 of the urethra, and as a result, the lumen of the urethra 10 becomes narrower. Since the cross-sectional area of the portion (stenosis portion 30) where the scar tissue 31 is formed in the urethra 10 is narrower than other portions of the urethra 10, it is difficult for urine to pass therethrough. When suffering from urethral stricture, urination disorders such as urine not being smoothly drained or urine being not drained at all are caused.

尿道狭窄症の治療方法として、例えば、ブジー(尿道拡張具)やバルーン、尿道切開刀やレーザーなどの医療器具を経尿道的に尿道内に導入し、これらの医療器具により狭窄部を拡張、切開等することで狭窄部を治療する方法が試みられている。この方法によれば、一時的な治療効果は得られるものの、一旦治療した後に、狭窄部30が再度形成されてしまい、尿道狭窄症を再発する可能性が極めて高い。瘢痕組織31の周囲や瘢痕組織31下にある尿道海綿体13が尿道10内を流れる液体(例えば、尿や体液)に常時晒されることで持続的な炎症反応が誘発されて上皮細胞の再建が阻害されるためである。   As a treatment method for urethral strictures, for example, medical instruments such as bougie (urethral dilator), balloon, urethral knife and laser are transurethrally introduced into the urethra, and these strictures are expanded and incised. The method of treating a stenosis part is tried by doing. According to this method, although a temporary therapeutic effect can be obtained, the stenosis 30 is formed again after the treatment once, and the possibility of recurrence of urethral stricture is very high. The urethral cavernous body 13 around the scar tissue 31 and under the scar tissue 31 is constantly exposed to fluid flowing in the urethra 10 (for example, urine and body fluid), thereby inducing a persistent inflammatory reaction and reconstructing epithelial cells. It is because it is inhibited.

以下、図4及び図5を参照して、本実施形態に係る医療システム1の構成について説明する。   Hereinafter, with reference to FIG.4 and FIG.5, the structure of the medical system 1 which concerns on this embodiment is demonstrated.

医療システム1は、図4、5に示すように、医療用処置具100と、第1押出部材120と、第2押出部材130と、規制部140と、を有する。   As shown in FIGS. 4 and 5, the medical system 1 includes a medical treatment instrument 100, a first pushing member 120, a second pushing member 130, and a regulating unit 140.

医療用処置具100は、概説すると、尿道10に形成された狭窄部30に上皮機能を提供する医療材料Sを配置するための医療用処置具100である。医療用処置具100は、尿道10内に挿通され、尿道10内のY方向(長軸方向)に伸縮可能とし、収縮状態において周方向に3つの層をなす本体部110と、本体部110の最内層に設けられ、押出されることによりY方向(挿通方向)の先端側に移動して本体部110を伸長させるとともに、伸長状態において本体部110の尿道10内における位置を維持可能とする伸長部111Aと、外周113Dに医療材料Sを配置可能な状態で、本体部110の最外層に設けられ、伸長部111Aに沿って移動し本体部110を収縮させる移動部113Cと、を有する。以下、詳述する。   In general, the medical treatment instrument 100 is a medical treatment instrument 100 for placing a medical material S that provides an epithelial function in a narrowed portion 30 formed in the urethra 10. The medical treatment instrument 100 is inserted into the urethra 10, is extendable in the Y direction (long axis direction) in the urethra 10, and includes a main body 110 that forms three layers in the circumferential direction in the contracted state, and the main body 110. An extension that is provided in the innermost layer and moves to the tip side in the Y direction (insertion direction) by being pushed out to extend the main body 110 and to maintain the position of the main body 110 in the urethra 10 in the extended state. 111A and a moving part 113C that is provided on the outermost layer of the main body part 110 and moves along the extending part 111A and contracts the main body part 110 in a state where the medical material S can be disposed on the outer periphery 113D. Details will be described below.

医療用処置具100は、尿道10に形成された狭窄部30を処置した処置部30A(図6参照)に上皮機能を提供する医療材料Sを配置するための処置具であって、本体部110と、伸長部111Aと、移動部113Cと、を有する。ここでの医療材料とは、上皮細胞を含む植皮シート、例えば、口腔粘膜シート、陰茎包皮シートなどが用いられ、また、上皮細胞が播種されたコラーゲンシートなども含まれる。また、上皮細胞を含まず、尿の浸潤を防止する機能を有する生体親和性材料より構成されるシート、ゲルなども含まれる。また、尿道粘膜の再生を促す因子や刺激を提供する材料も含まれる。形状はシートに限定されず、ゲル状、液状など治療部位に留置可能である形状であれば構わない。ここでいう処置は、例えば、瘢痕組織31を切開、切削、切除などすることを含みうる。また、本明細書における「上皮機能」とは、尿などの液体及び尿道10に含まれる炎症惹起成分が尿道海綿体13に接触することを防止もしくは低減するバリア機能を意味する。   The medical treatment tool 100 is a treatment tool for placing a medical material S that provides an epithelial function in a treatment part 30A (see FIG. 6) that has treated the stenosis part 30 formed in the urethra 10, and includes a main body part 110. And an extending part 111A and a moving part 113C. Examples of the medical material used herein include skin graft sheets containing epithelial cells, such as oral mucosa sheets, penile foreskin sheets, and collagen sheets seeded with epithelial cells. Also included are sheets, gels and the like that are composed of a biocompatible material that does not contain epithelial cells and has a function of preventing urine infiltration. Also included are materials that provide factors and stimuli that promote regeneration of the urethral mucosa. The shape is not limited to a sheet, and any shape that can be placed in a treatment site, such as a gel or liquid, may be used. The treatment here may include, for example, incision, cutting, excision, and the like of the scar tissue 31. In addition, the “epithelial function” in the present specification means a barrier function that prevents or reduces the contact of the urinary cavernous body 13 with a liquid such as urine and an inflammation-inducing component contained in the urethra 10.

本体部110は、尿道10内を挿通可能であって、Y方向に摺動可能な入れ子構造をなす3つの管状部材111〜113からなる。本体部110は、入れ子状態において、最内周から順に、第1管状部材(最内周管状部材)111、第2管状部材112、第3管状部材(最外周管状部材)113と構成される。第1管状部材111〜第3管状部材113はそれぞれ、中空の円筒形状によって構成される。   The main body 110 includes three tubular members 111 to 113 that can be inserted through the urethra 10 and have a nested structure that can slide in the Y direction. The main body 110 is configured as a first tubular member (innermost peripheral tubular member) 111, a second tubular member 112, and a third tubular member (outermost peripheral tubular member) 113 in order from the innermost periphery in a nested state. Each of the first tubular member 111 to the third tubular member 113 is configured by a hollow cylindrical shape.

第1管状部材111は、図4、5に示すように、第1管状部材111及び第2管状部材112をY方向の先端側に押し出す第1押出部材120により押されて、本体部110をY方向に伸長させる伸長部111Aを有する。   As shown in FIGS. 4 and 5, the first tubular member 111 is pushed by the first pushing member 120 that pushes the first tubular member 111 and the second tubular member 112 to the tip end side in the Y direction, and the main body 110 is moved to the Y direction. It has an extending portion 111A that extends in the direction.

伸長部111Aは、第1押出部材120の先端部121に突き当てられることによって押されて、本体部110をY方向に伸長させる。伸長部111Aは、図5に示すように、第1押出部材120の外径より小さく形成されるテーパ形状によって構成される。伸長部111Aは、第1押出部材120の先端部121に突き当てられることによって、伸長状態において本体部110の尿道10内における位置が維持される。   The extending portion 111A is pushed by being abutted against the distal end portion 121 of the first pushing member 120 and extends the main body portion 110 in the Y direction. As shown in FIG. 5, the extending portion 111 </ b> A is configured by a tapered shape formed smaller than the outer diameter of the first push member 120. The extending portion 111A is abutted against the distal end portion 121 of the first pushing member 120, so that the position of the main body portion 110 in the urethra 10 is maintained in the extended state.

また、第1管状部材111は、図5に示すように、Y方向の基端側においてX方向の外方に延在するフランジ部111Bを有する。なお、第1管状部材111の先端側には尿道10内への導入時に医療材料Sのヨレを防止するためのカバー(不図示)が設けられていてもよい。   Further, as shown in FIG. 5, the first tubular member 111 has a flange portion 111B extending outward in the X direction on the proximal end side in the Y direction. Note that a cover (not shown) for preventing the medical material S from twisting when introduced into the urethra 10 may be provided on the distal end side of the first tubular member 111.

第2管状部材112は、Y方向の先端側においてX方向の内方に延在するフランジ部112Aと、Y方向の基端側においてX方向の外方に延在するフランジ部112Bと、Y方向の基端側においてX方向の内方に延在するフランジ部112Cと、を有する。   The second tubular member 112 includes a flange portion 112A that extends inward in the X direction on the distal end side in the Y direction, a flange portion 112B that extends outward in the X direction on the proximal end side in the Y direction, and a Y direction. And a flange portion 112C extending inward in the X direction on the base end side.

第3管状部材113は、第2管状部材112及び第3管状部材113をY方向の先端側に押し出す第2押出部材130により押されて、本体部110を収縮させ入れ子状態とする移動部113Cを有する。   The third tubular member 113 is pushed by the second pushing member 130 that pushes the second tubular member 112 and the third tubular member 113 to the front end side in the Y direction, and the moving portion 113C that contracts the main body portion 110 to be in a nested state. Have.

第3管状部材113は、Y方向の先端側においてX方向の内方に延在するフランジ部113Aと、Y方向の基端側においてX方向の内方に延在するフランジ部113Bと、を有する。また、第3管状部材113の外周113Dに、上皮機能を提供する医療材料Sが配置可能に構成されてなる。   The third tubular member 113 has a flange portion 113A that extends inward in the X direction on the distal end side in the Y direction, and a flange portion 113B that extends inward in the X direction on the proximal end side in the Y direction. . In addition, the medical material S that provides an epithelial function can be arranged on the outer periphery 113D of the third tubular member 113.

第1管状部材111〜第3管状部材113を構成する材料は、例えば、ポリオレフィン、ポリオレフィンの架橋体、ポリスチレン、ポリカーボネイト、ポリ塩化ビニル、ポリ塩化ビニリデン、ポリアミド、ポリアミドエラストマー、ポリエステル、ポリエステルエラストマー、ポリウレタン、ポリウレタンエラストマー、フッ素樹脂、メタクリル樹脂、フェノール樹脂、メラミン樹脂、ポリイミドなどの高分子材料またはこれらの混合物である。ポリオレフィンは、例えば、ポリエチレン、ポリプロピレン、ポリブテン、エチレン−プロピレン共重合体、エチレン−酢酸ビニル共重合体、アイオノマー、またはこれら2種以上の混合物である。   The material constituting the first tubular member 111 to the third tubular member 113 is, for example, polyolefin, a cross-linked polyolefin, polystyrene, polycarbonate, polyvinyl chloride, polyvinylidene chloride, polyamide, polyamide elastomer, polyester, polyester elastomer, polyurethane, It is a polymer material such as polyurethane elastomer, fluororesin, methacrylic resin, phenol resin, melamine resin, polyimide, or a mixture thereof. The polyolefin is, for example, polyethylene, polypropylene, polybutene, ethylene-propylene copolymer, ethylene-vinyl acetate copolymer, ionomer, or a mixture of two or more thereof.

第1管状部材111、第2管状部材112、及び第3管状部材113はそれぞれ、上述のフランジ部が設けられるため、第1押出部材120が伸長部111AをY方向の先端側に押し出すことによって、本体部110が伸長した状態となる。以下、そのメカニズムについて説明する。   Since each of the first tubular member 111, the second tubular member 112, and the third tubular member 113 is provided with the flange portion described above, the first pushing member 120 pushes the elongated portion 111A toward the distal end side in the Y direction. The main body 110 is in an extended state. Hereinafter, the mechanism will be described.

第1押出部材120が伸長部111AをY方向の先端側に押し出すことによって、まず、第1管状部材111が、Y方向の先端側に移動し、第1管状部材111のフランジ部111B及び第2管状部材112のフランジ部112Aが係止する。そしてさらに、第1押出部材120が伸長部111AをY方向の先端側に押し出すことによって、第1管状部材111及び第2管状部材112が、Y方向の先端側に移動し、第2管状部材112のフランジ部112B及び第3管状部材113のフランジ部113Aが係止し(図5参照)、本体部110がY方向に伸長した状態となる。なお、第1押出部材120は、第1管状部材111及び第2管状部材112を押し出した後に、第1管状部材111及び第2管状部材112によって第3管状部材113をY方向の先端側に押し出してもよい。   When the first pushing member 120 pushes the elongated portion 111A toward the distal end side in the Y direction, first, the first tubular member 111 moves to the distal end side in the Y direction, and the flange portion 111B and the second portion of the first tubular member 111 are moved. The flange portion 112A of the tubular member 112 is locked. Further, when the first push-out member 120 pushes the extending portion 111A to the tip end side in the Y direction, the first tubular member 111 and the second tubular member 112 move to the tip end side in the Y direction, and the second tubular member 112 is moved. The flange portion 112B and the flange portion 113A of the third tubular member 113 are locked (see FIG. 5), and the main body portion 110 extends in the Y direction. The first pushing member 120 pushes the first tubular member 111 and the second tubular member 112, and then pushes the third tubular member 113 to the front end side in the Y direction by the first tubular member 111 and the second tubular member 112. May be.

一方、第1管状部材111、第2管状部材112、及び第3管状部材113は、それぞれ上述のフランジ部が設けられるため、第2押出部材130が移動部113CをY方向の先端側に押し出すことによって、本体部110が収縮され入れ子状態となる。以下、そのメカニズムについて説明する。   On the other hand, since the first tubular member 111, the second tubular member 112, and the third tubular member 113 are each provided with the above-described flange portion, the second pushing member 130 pushes the moving portion 113C to the tip side in the Y direction. As a result, the main body 110 is contracted into a nested state. Hereinafter, the mechanism will be described.

本体部110が伸長した状態において、第2押出部材130が移動部113CをY方向の先端側に押し出すことによって、まず、第3管状部材113が、Y方向の先端側に移動し、第3管状部材113のフランジ部113B及び第2管状部材112のフランジ部112B、112Cが係止する。そしてさらに、第2押出部材130が移動部113CをY方向の先端側に押し出すことによって、第3管状部材113及び第2管状部材112がY方向の先端側に移動し、第2管状部材112のフランジ部112C及び第1管状部材111のフランジ部111Bが係止し、本体部110が収縮され入れ子状態となる。なお、第2押出部材130は、第2管状部材112及び第3管状部材113を押し出した後に、第2管状部材112及び第3管状部材113によって第1管状部材111を押し出してもよい。   In the state in which the main body 110 is extended, the second pushing member 130 pushes the moving portion 113C to the tip end side in the Y direction, so that the third tubular member 113 first moves to the tip end side in the Y direction, and the third tubular member The flange 113B of the member 113 and the flanges 112B and 112C of the second tubular member 112 are locked. Further, when the second push-out member 130 pushes the moving portion 113C to the tip end side in the Y direction, the third tubular member 113 and the second tubular member 112 move to the tip end side in the Y direction, and the second tubular member 112 The flange portion 112C and the flange portion 111B of the first tubular member 111 are locked, and the main body portion 110 is contracted to be in a nested state. In addition, the 2nd extrusion member 130 may extrude the 1st tubular member 111 by the 2nd tubular member 112 and the 3rd tubular member 113 after pushing out the 2nd tubular member 112 and the 3rd tubular member 113.

第1押出部材120は、伸長部111Aを押して、第1管状部材111及び第2管状部材112をY方向の先端側に押し出すことによって、本体部110をY方向に伸長させる。第1押出部材120は、例えば、内視鏡であり得る。第1押出部材120が内視鏡であれば、本体部110を構成する第1管状部材111〜第3管状部材113に透明な部材を用いることにより、尿道10内の様子を観察しながら、本体部110を尿道10内に導入することができ、手技が容易となる。   The first pushing member 120 pushes the extending portion 111A and pushes the first tubular member 111 and the second tubular member 112 toward the distal end side in the Y direction, thereby extending the main body portion 110 in the Y direction. The first push member 120 can be, for example, an endoscope. If the first push-out member 120 is an endoscope, a transparent member is used for the first tubular member 111 to the third tubular member 113 constituting the main body portion 110, thereby observing the inside of the urethra 10 while the main body The part 110 can be introduced into the urethra 10 and the procedure becomes easy.

第2押出部材130は、移動部113Cを押して、第2管状部材112及び第3管状部材113をY方向の先端側に押し出すことによって、本体部110を収縮させ入れ子状態とする。第2押出部材130は、移動部113Cに対して、例えば接着剤によって固定される。なお、これに限定されず、ろう付け、融着などであってもよい。さらに第2押出部材130は、第3管状部材113と一体的に構成されていてもよい。また、第2押出部材130は、押し当て、嵌合、磁性部材などにより移動部113Cに一時的に接続され、取り外し可能であってもよい。   The second pushing member 130 pushes the moving part 113C and pushes the second tubular member 112 and the third tubular member 113 toward the distal end side in the Y direction, thereby contracting the main body part 110 to be a nested state. The second pushing member 130 is fixed to the moving part 113C by, for example, an adhesive. Note that the present invention is not limited to this, and may be brazing, fusion bonding, or the like. Further, the second pushing member 130 may be configured integrally with the third tubular member 113. Further, the second pushing member 130 may be temporarily connected to the moving portion 113C by pressing, fitting, a magnetic member, or the like, and may be removable.

規制部140は、図4に示すように、移動部113Cが第2押出部材130により押されて、本体部110を入れ子状態とする際に、第1管状部材111が先端側に移動することを規制する。規制部140は、例えば糸であって、一端が第1管状部材111に固定され、他端が、尿道10を介して体外に導出され、術者が把持可能となっている。   As shown in FIG. 4, the restricting portion 140 is configured to prevent the first tubular member 111 from moving toward the distal end side when the moving portion 113 </ b> C is pushed by the second push-out member 130 and the main body portion 110 is nested. regulate. The restricting portion 140 is, for example, a thread, and one end is fixed to the first tubular member 111 and the other end is led out of the body via the urethra 10 so that the operator can grasp it.

次に、図6〜図10を参照して、本実施形態に係る医療システム1の使用方法について説明する。なお、図6〜図10において、理解の容易のため、医療システム1については正面図で示し、その他は正面断面図で示す。   Next, with reference to FIGS. 6-10, the usage method of the medical system 1 which concerns on this embodiment is demonstrated. 6 to 10, for easy understanding, the medical system 1 is shown in a front view, and the others are shown in a front sectional view.

本実施形態に係る医療用処置具100の尿道10内の導入に先立って、術者は、医療分野で公知の内視鏡を尿道10内に導入して尿道10内を観察しつつ、内視鏡に設けられるチャネル(不図示)を介して、所定の処置具を尿道10内に導入して、尿道10内に形成された瘢痕組織31に対して、切開、切削、切除などの処置を行い、狭窄部30を処置して処置部30Aを形成する。なお、第1押出部材120が内視鏡であるときは、第1押出部材120を用いることによって尿道10内を観察することができる。   Prior to the introduction of the medical treatment tool 100 according to the present embodiment into the urethra 10, the operator introduces an endoscope known in the medical field into the urethra 10 and observes the inside of the urethra 10 while A predetermined treatment tool is introduced into the urethra 10 through a channel (not shown) provided in the mirror, and the scar tissue 31 formed in the urethra 10 is subjected to treatment such as incision, cutting, and excision. The stenosis part 30 is treated to form a treatment part 30A. When the first push member 120 is an endoscope, the inside of the urethra 10 can be observed by using the first push member 120.

次に、術者は、内視鏡を尿道10内から取り出し、矩形状の上皮機能を提供する医療材料Sを、第3管状部材113の外周113Dに巻き付けることによって、第3管状部材113の外周113Dにマウントする。   Next, the surgeon removes the endoscope from the urethra 10 and wraps the medical material S that provides a rectangular epithelial function around the outer periphery 113D of the third tubular member 113, whereby the outer periphery of the third tubular member 113 is wound. Mount on 113D.

次に、術者は、図6に示すように、上皮機能を提供する医療材料Sを第3管状部材113の外周113Dにマウントした状態で、医療用処置具100を尿道10の入口Eから挿入する。   Next, as shown in FIG. 6, the surgeon inserts the medical treatment tool 100 from the entrance E of the urethra 10 in a state where the medical material S that provides an epithelial function is mounted on the outer periphery 113 </ b> D of the third tubular member 113. To do.

次に、術者は、図7に示すように、第1押出部材120を第1管状部材111の内部に挿入し、第1押出部材120の先端部121を伸長部111Aに突き当てる。   Next, as shown in FIG. 7, the surgeon inserts the first pushing member 120 into the first tubular member 111 and abuts the distal end portion 121 of the first pushing member 120 against the extending portion 111A.

次に、術者は、図8に示すように、第1押出部材120をY方向の先端側に押し出して、入れ子状態であった本体部110をY方向に伸長させる。このとき、第1管状部材111の先端が、Y方向において、処置部30Aを超えるまで、第1押出部材120を押し出す。   Next, as shown in FIG. 8, the surgeon pushes the first push-out member 120 toward the distal end side in the Y direction, and extends the body portion 110 that has been in the nested state in the Y direction. At this time, the 1st extrusion member 120 is extruded until the front-end | tip of the 1st tubular member 111 exceeds 30 A of treatment parts in a Y direction.

なお、第1管状部材111は、処置部30Aの内周に対して密着する程度の外径を有していることが好ましい。この構成によれば、瘢痕組織31を処置した際に発生する出血を、図8の状態において、適切に止血することができ、内視鏡の視野が良好となり、手技が容易となる。   In addition, it is preferable that the 1st tubular member 111 has an outer diameter of the grade which closely_contact | adheres with respect to the inner periphery of 30 A of treatment parts. According to this configuration, bleeding that occurs when the scar tissue 31 is treated can be appropriately stopped in the state shown in FIG. 8, the visual field of the endoscope is improved, and the procedure is facilitated.

次に、術者は、規制部140を把持して第1管状部材111がY方向の先端側に移動することを規制しつつ、第2押出部材130をY方向の先端側に押し出すことによって(図8の矢印参照)、第3管状部材113及び第2管状部材112を先端側に押し出し、本体部110を収縮させ入れ子状態とする。この結果、図9に示すように、第3管状部材113の外周113Dにマウントされた上皮機能を提供する医療材料Sが処置部30Aに当接した状態で留置される。   Next, the surgeon grasps the restricting portion 140 and restricts the movement of the first tubular member 111 toward the distal end in the Y direction, and pushes the second push-out member 130 toward the distal end in the Y direction ( 8), the third tubular member 113 and the second tubular member 112 are pushed out to the distal end side, and the main body 110 is contracted to be in a nested state. As a result, as shown in FIG. 9, the medical material S that provides the epithelial function mounted on the outer periphery 113 </ b> D of the third tubular member 113 is left in contact with the treatment portion 30 </ b> A.

次に、術者は、図10に示すように、第1押出部材120を尿道10内から抜去し、本体部110及び上皮機能を提供する医療材料Sを尿道10内に留置する。この状態において、本体部110は、尿道10の入口Eから処置部30Aに亘って留置されることなく、処置部30A近傍にのみ留置される。また、この一連の作業によって、処置部30Aの止血を行った状態で、上皮機能を提供する医療材料Sを、容易に処置部30Aに当接した状態で留置することができる。このように、上皮機能を提供する医療材料Sを処置部30Aに当接した状態で留置することによって、処置部30Aに上皮細胞を生着させ、処置部30Aの再狭窄を防止することができる。   Next, as shown in FIG. 10, the surgeon removes the first pushing member 120 from the urethra 10, and places the main body 110 and the medical material S that provides the epithelial function in the urethra 10. In this state, the main body 110 is not placed from the entrance E of the urethra 10 to the treatment portion 30A, but is placed only in the vicinity of the treatment portion 30A. In addition, through this series of operations, the medical material S providing the epithelial function can be easily placed in contact with the treatment portion 30A in a state where the treatment portion 30A is hemostatic. In this way, by placing the medical material S that provides an epithelial function in contact with the treatment portion 30A, it is possible to engraft the epithelial cells in the treatment portion 30A and prevent restenosis of the treatment portion 30A. .

そして、術者は、所定期間経過後に、第2押出部材130を基端側に引くことによって(図10矢印参照)、本体部110を尿道10内から抜去する。   Then, the operator pulls out the main body 110 from the urethra 10 by pulling the second pushing member 130 toward the proximal end side after a predetermined period of time (see the arrow in FIG. 10).

なお、尿道10内に留置された本体部110の第1管状部材111の内周に、外方に拡張可能なバルーンが設けられた公知のバルーンカテーテルをバルーンが収縮した状態で挿入し、その後バルーンを拡張し、バルーンが第1管状部材111の内周面に当接した状態で、バルーンカテーテルを抜去することによって本体部110を抜去してもよい。   A known balloon catheter provided with an outwardly expandable balloon is inserted into the inner circumference of the first tubular member 111 of the main body 110 placed in the urethra 10 in a deflated state, and then the balloon The main body 110 may be removed by removing the balloon catheter while the balloon is in contact with the inner peripheral surface of the first tubular member 111.

以上説明したように、本実施形態に係る医療用処置具100は、尿道10に形成された狭窄部30を処置した処置部30Aに上皮機能を提供する医療材料Sを配置するための医療用処置具100である。医療用処置具100は、尿道10内に挿通され、尿道10内のY方向に伸縮可能とし、収縮状態において周方向に複数の層をなす本体部110と、本体部110の最内層に設けられ、押出されることによりY方向の先端側に移動して本体部110を伸長させるとともに、伸長状態において本体部110の尿道10内における位置を維持可能とする伸長部111Aと、外周113Dに医療材料Sを配置可能な状態で本体部110の最外層に設けられ、伸長部111Aに沿って移動し本体部110を収縮させる移動部113Cと、を有する。この構成であれば、上皮機能を提供する医療材料Sを尿道10入口から処置部30Aまで導入する際に、まず、伸長部111Aが押出されることによりY方向の先端側に移動して本体部110を伸長させ、本体部110の最内層を処置部30Aまで導入する。その後、移動部113Cが伸長部111Aに沿って移動し本体部110を収縮させる。この一連の作業によって、上皮機能を提供する医療材料Sを処置部30Aに留置させることができる。したがって、この医療用処置具100によれば、上皮機能を提供する医療材料Sを処置部30Aに所定期間留置する際に、処置部30Aの止血を行った状態で、上皮機能を提供する医療材料Sを、容易に処置部30Aに留置することのできる医療用処置具100を提供することができる。   As described above, the medical treatment tool 100 according to the present embodiment is a medical treatment for placing the medical material S that provides an epithelial function in the treatment portion 30A that has treated the stenosis portion 30 formed in the urethra 10. Tool 100. The medical treatment instrument 100 is inserted into the urethra 10 and can be expanded and contracted in the Y direction in the urethra 10, and is provided in the innermost layer of the main body 110 and the main body 110 that forms a plurality of layers in the circumferential direction in the contracted state. The body portion 110 is extended by being pushed and moved to the front end side in the Y direction, and the medical material is provided on the outer periphery 113D and the extension portion 111A that can maintain the position of the body portion 110 in the urethra 10 in the extended state. The movable portion 113C is provided on the outermost layer of the main body 110 in a state where S can be disposed, and moves along the extending portion 111A to contract the main body 110. With this configuration, when the medical material S that provides the epithelial function is introduced from the entrance of the urethra 10 to the treatment portion 30A, first, the extension portion 111A is pushed to move to the distal end side in the Y direction to move to the main body portion. 110 is extended and the innermost layer of the main body 110 is introduced to the treatment section 30A. Thereafter, the moving part 113C moves along the extending part 111A and contracts the main body part 110. Through this series of operations, the medical material S providing the epithelial function can be placed in the treatment section 30A. Therefore, according to the medical treatment tool 100, when the medical material S that provides epithelial function is placed in the treatment section 30A for a predetermined period, the medical material that provides epithelial function in a state in which the treatment section 30A is hemostatic. It is possible to provide a medical treatment instrument 100 that can easily place S in the treatment section 30A.

また、本体部110は、入れ子構造をなす3つの管状部材111〜113からなり、伸長部111Aは、3つの管状部材111〜113のうち最内周に位置する第1管状部材111に設けられ、第1管状部材111及び第2管状部材112を先端側に押し出す第1押出部材120により押されて本体部110を伸長させ、移動部113Cは、3つの管状部材111〜113のうち最外周に位置する最外周管状部材113に設けられ、第2管状部材112及び第3管状部材113を先端側に押し出す第2押出部材130により押されて本体部110を収縮させる。この構造によれば、上皮機能を提供する医療材料Sを尿道10入口から処置部30Aまで導入する際に、まず、伸長部111Aが第1押出部材120により押されることによって、入れ子状態の管状部材111〜113をY方向の先端側に押し出して、最内周管状部材111が処置部30Aまで導入されるように、3つの管状部材111〜113からなる本体部110をY方向に伸長させる。その後、移動部113Cが第2押出部材130により押されることによって、伸長状態の管状部材111〜113を先端側に押し出して本体部110を収縮させ入れ子状態とする。この一連の作業によって、上皮機能を提供する医療材料Sを処置部30Aに留置させることができる。したがって、この医療用処置具100によれば、上皮機能を提供する医療材料Sを処置部30Aに所定期間留置する際に、処置部30Aの止血を行った状態で、上皮機能を提供する医療材料Sを、容易に処置部30Aに留置することのできる医療用処置具100を提供することができる。   The main body 110 is composed of three tubular members 111 to 113 having a nested structure, and the elongated portion 111A is provided on the first tubular member 111 located on the innermost periphery of the three tubular members 111 to 113, The first tubular member 111 and the second tubular member 112 are pushed by the first push-out member 120 that pushes the distal end side to the front end side to extend the main body 110, and the moving portion 113 </ b> C is positioned on the outermost periphery among the three tubular members 111 to 113. The main body 110 is contracted by being pushed by the second pushing member 130 that is provided on the outermost tubular member 113 and pushes the second tubular member 112 and the third tubular member 113 to the distal end side. According to this structure, when the medical material S providing the epithelial function is introduced from the entrance of the urethra 10 to the treatment portion 30A, first, the elongated portion 111A is pushed by the first pushing member 120, so that the nested tubular member 111 to 113 are pushed out to the front end side in the Y direction, and the main body portion 110 including the three tubular members 111 to 113 is extended in the Y direction so that the innermost peripheral tubular member 111 is introduced to the treatment portion 30A. Thereafter, when the moving part 113C is pushed by the second push-out member 130, the expanded tubular members 111 to 113 are pushed out toward the distal end side, and the main body part 110 is contracted to be in a nested state. Through this series of operations, the medical material S providing the epithelial function can be placed in the treatment section 30A. Therefore, according to the medical treatment tool 100, when the medical material S that provides epithelial function is placed in the treatment section 30A for a predetermined period, the medical material that provides epithelial function in a state in which the treatment section 30A is hemostatic. It is possible to provide a medical treatment instrument 100 that can easily place S in the treatment section 30A.

また、伸長部111Aは、第1押出部材120の先端部121に突き当てられることによって押されて、本体部110をY方向に伸長させる。このため、容易な動作によって、伸長部111Aが第1押出部材120に押されるため、手技が容易となる。   In addition, the extending portion 111A is pushed by being abutted against the distal end portion 121 of the first pushing member 120 and extends the main body portion 110 in the Y direction. For this reason, since the extending portion 111A is pushed by the first pushing member 120 by an easy operation, the procedure becomes easy.

また、移動部113Cが、本体部110を収縮させる際に、第1管状部材111がY方向の先端側に移動することを規制する規制部140をさらに有する。このため、より確実に第1管状部材111を処置部30Aに配置することができる。   Further, when the moving part 113C contracts the main body part 110, the moving part 113C further includes a restricting part 140 that restricts the first tubular member 111 from moving to the front end side in the Y direction. For this reason, the 1st tubular member 111 can be arrange | positioned to the treatment part 30A more reliably.

また、医療システム1は、上述の医療用処置具100と、第1押出部材120と、第2押出部材130と、を有する。このため、処置部30Aの止血を行った状態で、上皮機能を提供する医療材料Sを、容易に処置部30Aに留置することのできる医療システム1を提供することができる。   In addition, the medical system 1 includes the above-described medical treatment instrument 100, a first push member 120, and a second push member 130. For this reason, it is possible to provide the medical system 1 in which the medical material S providing the epithelial function can be easily placed in the treatment section 30A in a state where the treatment section 30A is hemostatic.

また、第1押出部材120が内視鏡であれば、内視鏡で尿道10内を観察しつつ、本体部110を処置部30Aに留置することができるため手技が容易となる。   Further, if the first push-out member 120 is an endoscope, the main body 110 can be placed in the treatment section 30A while observing the inside of the urethra 10 with an endoscope, so that the procedure becomes easy.

なお、本発明は上述した実施形態に限定されるものではなく、特許請求の範囲内で種々変更することができる。   In addition, this invention is not limited to embodiment mentioned above, A various change can be made within a claim.

上述した実施形態では、本体部110は、3つの管状部材111〜113から構成されたが、2つの管状部材、または4つ以上の管状部材から構成されていてもよい。   In the embodiment described above, the main body 110 is configured by the three tubular members 111 to 113, but may be configured by two tubular members or four or more tubular members.

また、上述した実施形態では、本体部110を入れ子状態とする際に、第1管状部材111が先端側に移動することを規制するための規制部140を備えていたが、規制部140は必ずしも設けられる必要はない。   In the above-described embodiment, when the main body 110 is placed in the nested state, the first tubular member 111 is provided with the restricting portion 140 for restricting movement to the distal end side. However, the restricting portion 140 is not necessarily provided. There is no need to be provided.

また、上述した実施形態では、第1管状部材111及び第2管状部材112が、完全に伸長した後に、第3管状部材113が先端側に押し出されたが、第1管状部材111及び第2管状部材112が、完全に伸長する前に、第3管状部材113が先端側に押し出されてもよい。   In the above-described embodiment, the first tubular member 111 and the second tubular member 112 are pushed out to the distal end side after the first tubular member 111 and the second tubular member 112 are completely extended. Before the member 112 is fully extended, the third tubular member 113 may be pushed to the distal end side.

また、上述した実施形態では、本体部110は、入れ子構造をなす3つの管状部材111〜113からなった。しかしながら、本体部は内周側が先端側に移動して伸長した後に、外周側が先端側に移動して収縮する構造であれば特に限定されず、一体型で内周側から伸長する構造等であってもよい。   In the above-described embodiment, the main body 110 includes the three tubular members 111 to 113 having a nested structure. However, the main body portion is not particularly limited as long as the outer peripheral side moves to the distal end side and contracts after the inner peripheral side moves to the distal end side, and is not particularly limited. May be.

また、上述した実施形態では、医療システム1は、尿道10の狭窄部30に適用された。しかしながら、これに限定されず、尿管、気管、食道、胆管、膵管、消化管、耳管、鼻腔管などの各種体腔内に適用することが可能である。   In the above-described embodiment, the medical system 1 is applied to the narrowed portion 30 of the urethra 10. However, the present invention is not limited to this, and can be applied to various body cavities such as the ureter, trachea, esophagus, bile duct, pancreatic duct, digestive tract, ear canal, and nasal canal.

以下、上述した実施形態の伸長部に関する改変例を例示する。   Hereinafter, the modification example regarding the expansion | extension part of embodiment mentioned above is illustrated.

<改変例1>
図11は、改変例1に係る医療用処置具200の第1管状部材211の先端部における側面断面図である。上述した実施形態では、伸長部111Aは、第1押出部材120の外径より小さく形成されたテーパ形状によって構成された。しかしながら、改変例1に係る伸長部211Aは、図11に示すように、第1管状部材211の内周に設けられ、第1押出部材120の先端部121が突き当たり可能な程度に内方に突出する形状であってもよい。伸長部211Aは、第1管状部材211の内周に、例えば接着剤によって接着される。なお、伸長部211Aは、第1管状部材211に対して一体的に構成されてもよい。この構成によれば、伸長部211Aは、第1押出部材120の先端部121に突き当てられることによって押される。このため、容易な動作によって、伸長部211Aが第1押出部材120に押されるため、手技が容易となる。
<Modification 1>
FIG. 11 is a side cross-sectional view of the distal end portion of the first tubular member 211 of the medical treatment tool 200 according to Modification Example 1. FIG. In the above-described embodiment, the extending portion 111 </ b> A is configured by a tapered shape formed smaller than the outer diameter of the first push member 120. However, as shown in FIG. 11, the elongated portion 211 </ b> A according to Modification 1 is provided on the inner periphery of the first tubular member 211 and protrudes inward to the extent that the tip 121 of the first pushing member 120 can abut. The shape to do may be sufficient. The elongated portion 211A is bonded to the inner periphery of the first tubular member 211 with, for example, an adhesive. The elongated portion 211A may be configured integrally with the first tubular member 211. According to this configuration, the extending portion 211 </ b> A is pushed by being abutted against the distal end portion 121 of the first pushing member 120. For this reason, since the extension part 211A is pushed by the first pushing member 120 by an easy operation, the procedure becomes easy.

<改変例2>
図12は、改変例2に係る医療システム3の第1管状部材311及び第1押出部材320を示す概略図である。
<Modification 2>
FIG. 12 is a schematic diagram illustrating the first tubular member 311 and the first push member 320 of the medical system 3 according to Modification 2.

改変例2に係る医療システム3は、第1管状部材311及び第1押出部材320を有する。なお、その他の構成は、上述した実施形態と同様であるため、説明は省略する。   The medical system 3 according to the modified example 2 includes a first tubular member 311 and a first push member 320. Since other configurations are the same as those in the above-described embodiment, description thereof is omitted.

第1管状部材311の内周には、図12に示すように、第1磁性部(伸長部)311Aが設けられている。また、第1押出部材320は、内視鏡321と、内視鏡321を包むキャップ322と、キャップ322の外周に設けられる第2磁性部323と、を有する。第1磁性部311A及び第2磁性部323は互いに異なる磁性を有する。この構成であれば、第1押出部材320を第1管状部材311の内部に挿入することによって、第1磁性部311Aは、第1押出部材320の第2磁性部323に磁力によって接続される。このため、第1押出部材320がより確実に第1管状部材311を押すことができる。なお、キャップ322が設けられず、内視鏡321に直接第2磁性部323が設けられる構成であってもよい。   As shown in FIG. 12, a first magnetic part (extension part) 311 </ b> A is provided on the inner periphery of the first tubular member 311. The first push member 320 includes an endoscope 321, a cap 322 that wraps the endoscope 321, and a second magnetic unit 323 provided on the outer periphery of the cap 322. The first magnetic unit 311A and the second magnetic unit 323 have different magnetism. With this configuration, the first magnetic member 311 </ b> A is connected to the second magnetic portion 323 of the first push member 320 by magnetic force by inserting the first push member 320 into the first tubular member 311. For this reason, the 1st extrusion member 320 can push the 1st tubular member 311 more reliably. Note that the second magnetic unit 323 may be provided directly on the endoscope 321 without the cap 322 being provided.

<改変例3>
図13は、改変例3に係る医療システム4の第1管状部材411及び第1押出部材420を示す概略図である。
<Modification 3>
FIG. 13 is a schematic diagram showing the first tubular member 411 and the first push member 420 of the medical system 4 according to Modification 3.

改変例3に係る医療システム4は、第1管状部材411及び第1押出部材420を有する。なお、その他の構成は、上述した実施形態と同様であるため、説明は省略する。   The medical system 4 according to the modified example 3 includes a first tubular member 411 and a first pushing member 420. Since other configurations are the same as those in the above-described embodiment, description thereof is omitted.

第1管状部材411は、図13に示すように、挿入方向の先端側において、らせん状の溝形状からなる係合部(伸長部)411Aを有する。また、第1押出部材420は、内視鏡421と、内視鏡421を包むキャップ422と、キャップ422の外周に設けられ係合部411Aと互いに係合するらせん状の凸部423と、を有する。この構成であれば、第1押出部材420を第1管状部材411の内部に挿入することによって、係合部411Aは、第1押出部材420の凸部423と互いに係合して接続される。このため、第1押出部材420がより確実に第1管状部材411を押すことができる。   As shown in FIG. 13, the first tubular member 411 has an engaging portion (extending portion) 411 </ b> A having a spiral groove shape on the distal end side in the insertion direction. The first push-out member 420 includes an endoscope 421, a cap 422 that wraps the endoscope 421, and a spiral convex portion 423 that is provided on the outer periphery of the cap 422 and engages with the engaging portion 411A. Have. With this configuration, by inserting the first push member 420 into the first tubular member 411, the engaging portion 411A is engaged with and connected to the convex portion 423 of the first push member 420. For this reason, the 1st extrusion member 420 can push the 1st tubular member 411 more reliably.

<改変例4>
図14は、改変例4に係る医療システム5の第1管状部材511及び第1押出部材520を示す概略図である。
<Modification 4>
FIG. 14 is a schematic diagram illustrating the first tubular member 511 and the first push member 520 of the medical system 5 according to Modification 4.

改変例4に係る医療システム5は、第1管状部材511及び第1押出部材520を有する。なお、その他の構成は、上述した実施形態と同様であるため、説明は省略する。   The medical system 5 according to the modified example 4 includes a first tubular member 511 and a first push member 520. Since other configurations are the same as those in the above-described embodiment, description thereof is omitted.

第1管状部材511は、図14に示すように、挿入方向に延伸する溝形状からなる直線部511Bと、直線部511Bの先端側において周方向に延伸する溝形状からなる係合部(伸長部)511Aと、を有する。また、第1押出部材520は、内視鏡521と、内視鏡521を包むキャップ522と、キャップ522の外周に設けられ外方に突出する凸部523と、を有する。この構成であれば、第1押出部材520の凸部523が第1管状部材511の直線部511Bに沿うように、第1押出部材520を第1管状部材511の内部に挿入して、凸部523が直線部511Bの最先端部に当接した状態で、第1押出部材520を回転することによって、凸部523は、係合部511Aに係合されて、第1押出部材520及び第1管状部材511は接続される。このため、第1押出部材520がより確実に第1管状部材511を押すことができる。   As shown in FIG. 14, the first tubular member 511 includes a linear portion 511B having a groove shape extending in the insertion direction and an engaging portion (extending portion) having a groove shape extending in the circumferential direction on the distal end side of the linear portion 511B. ) 511A. The first push member 520 includes an endoscope 521, a cap 522 that encloses the endoscope 521, and a convex portion 523 that is provided on the outer periphery of the cap 522 and protrudes outward. If it is this structure, the 1st extrusion member 520 will be inserted in the inside of the 1st tubular member 511 so that the convex part 523 of the 1st extrusion member 520 may follow the linear part 511B of the 1st tubular member 511, and a convex part By rotating the first pushing member 520 in a state where the 523 is in contact with the most distal portion of the linear portion 511B, the convex portion 523 is engaged with the engaging portion 511A, and the first pushing member 520 and the first pushing member 520 are engaged. The tubular member 511 is connected. For this reason, the 1st extrusion member 520 can push the 1st tubular member 511 more reliably.

<改変例5>
図15、図16は、改変例5に係る医療システム6の第1管状部材611及び第1押出部材120を示す正面断面図である。なお、図15、16において、第1押出部材120は正面図で示す。
<Modification 5>
15 and 16 are front sectional views showing the first tubular member 611 and the first push member 120 of the medical system 6 according to Modification 5. 15 and 16, the first pushing member 120 is shown in a front view.

改変例5に係る医療システム6の第1管状部材611の内部には、図15に示すように、拡張変形可能な拡張部(伸長部)611A、及び拡張部611Aに加圧媒体を送るためのルーメン611Lを備える可撓性の中空部材612が設けられる。拡張部611Aは、具体的にはバルーンである。この構成であれば、第1押出部材120を第1管状部材611の内部に挿入した状態で、ルーメン611Lを介して加圧媒体を送ることによって、拡張部611Aを拡張させて、拡張部611Aが第1押出部材120を押圧して保持することができる。このため、第1押出部材120及び第1管状部材611は接続される。このため、第1押出部材120がより確実に第1管状部材611を押すことができる。なお、ルーメン611Lは、第1管状部材611の内部に全周的に配置されていても良く、また、図16に示すように第1管状部材611の管壁内に設けられていてもよい。   As shown in FIG. 15, inside the first tubular member 611 of the medical system 6 according to the modified example 5, an expansion part (extension part) 611A that can be expanded and deformed, and a pressure medium for sending to the expansion part 611A are sent. A flexible hollow member 612 having a lumen 611L is provided. Specifically, the expansion portion 611A is a balloon. If it is this composition, with the 1st extrusion member 120 inserted in the inside of the 1st tubular member 611, by sending a pressurizing medium via lumen 611L, expansion part 611A is expanded and expansion part 611A The first pushing member 120 can be pressed and held. For this reason, the 1st extrusion member 120 and the 1st tubular member 611 are connected. For this reason, the 1st extrusion member 120 can push the 1st tubular member 611 more reliably. Note that the lumen 611L may be arranged around the inside of the first tubular member 611, or may be provided in the tube wall of the first tubular member 611 as shown in FIG.

<改変例6>
図17は、改変例6に係る医療システム7の第1管状部材711の先端部における側面断面図であって、図17(A)は、第1管状部材711及び第1押出部材120が接続されている様子を示し、図17(B)は、第1管状部材711及び第1押出部材120の接続状態が解除された様子を示す図である。
<Modification 6>
FIG. 17 is a side cross-sectional view of the distal end portion of the first tubular member 711 of the medical system 7 according to Modification 6. FIG. 17A is a diagram in which the first tubular member 711 and the first pushing member 120 are connected. FIG. 17B is a diagram illustrating a state in which the connection state of the first tubular member 711 and the first push member 120 is released.

改変例6に係る医療システム7の第1管状部材711の内部には、3つの弾性部材(伸長部)711Aが設けられる。3つの弾性部材711A及び第1管状部材711は、例えば、接着剤によって固定される。この構成であれば、第1押出部材120を第1管状部材711の内部に挿入することによって、第1押出部材120及び第1管状部材711は弾性部材711Aによって接続する。なお、第1押出部材120を抜去する際は、第1押出部材120を所定角度回転する。この結果、第1押出部材120と弾性部材711Aと間の接触面積が減少して(図17(B)参照)、抜去が可能となる。この構成によれば、第1押出部材120がより確実に第1管状部材711を押すことができる。   Three elastic members (extension portions) 711A are provided inside the first tubular member 711 of the medical system 7 according to Modification Example 6. The three elastic members 711A and the first tubular member 711 are fixed by, for example, an adhesive. With this configuration, by inserting the first push member 120 into the first tubular member 711, the first push member 120 and the first tubular member 711 are connected by the elastic member 711A. In addition, when extracting the 1st extrusion member 120, the 1st extrusion member 120 is rotated a predetermined angle. As a result, the contact area between the first extruding member 120 and the elastic member 711A is reduced (see FIG. 17B), and can be removed. According to this structure, the 1st extrusion member 120 can push the 1st tubular member 711 more reliably.

<改変例7>
図18は、改変例7に係る医療システム8の第1押出部材820の構成を説明するための図である。第1押出部材820以外の構成は上述した実施形態と同様であるため、説明は省略する。
<Modification 7>
FIG. 18 is a view for explaining the configuration of the first push member 820 of the medical system 8 according to Modification 7. Since the configuration other than the first pushing member 820 is the same as that of the above-described embodiment, the description thereof is omitted.

改変例7に係る第1押出部材820は、図18に示すように、内視鏡821と、内視鏡821の外周に設けられ内視鏡821より剛性の低い可撓性の樹脂部材822と、を有する。樹脂部材822は、第1管状部材111の内周と固定可能に設けられる。樹脂部材822及び第1管状部材111の内周との固定方法は特に限定されず、例えば接着剤による接着である。   As shown in FIG. 18, the first push-out member 820 according to Modification 7 includes an endoscope 821 and a flexible resin member 822 that is provided on the outer periphery of the endoscope 821 and has lower rigidity than the endoscope 821. Have. The resin member 822 is provided so as to be fixed to the inner periphery of the first tubular member 111. The fixing method with the inner periphery of the resin member 822 and the 1st tubular member 111 is not specifically limited, For example, it is adhesion | attachment by an adhesive agent.

以下、改変例7に係る医療システム8を用いた手技について説明する。ここでは、第1押出部材820を抜去する手技についてのみ説明する。術者は、図18(A)に示すように、本体部110が処置部30Aに留置された状態において、内視鏡821のみを尿道10内から抜去する。そして、上皮機能を提供する医療材料Sを所定期間、処置部30Aに留置した後に、第2押出部材130を尿道10内から抜去する際に、樹脂部材822を同時に尿道10内から抜去する。この方法によれば、第2押出部材130が第3管状部材113を、樹脂部材822が第1管状部材111をそれぞれ同時に抜去するため、より確実に医療用処置具100を抜去することができる。   Hereinafter, a procedure using the medical system 8 according to Modification Example 7 will be described. Here, only the procedure for removing the first push member 820 will be described. As shown in FIG. 18A, the operator removes only the endoscope 821 from the urethra 10 in a state where the main body 110 is placed in the treatment section 30A. Then, after the medical material S providing the epithelial function is placed in the treatment portion 30A for a predetermined period, the resin member 822 is simultaneously removed from the urethra 10 when the second push-out member 130 is removed from the urethra 10. According to this method, the second push-out member 130 removes the third tubular member 113 and the resin member 822 simultaneously removes the first tubular member 111, so that the medical treatment instrument 100 can be more reliably removed.

<改変例8>
改変例8に係る医療システムは、改変例7に係る医療システム8に対して、第2押出部材130が移動部113Cに対して取外し可能に構成される。
<Modification 8>
The medical system according to Modification Example 8 is configured such that the second push-out member 130 is removable from the moving unit 113C with respect to the medical system 8 according to Modification Example 7.

以下、改変例8に係る医療システムを用いた手技について説明する。ここでは、第2押出部材130が第3管状部材113を先端側に押し出し、本体部110を入れ子状態とした後の手技について説明する。術者は、第2押出部材130を移動部から取外し尿道10内から抜去する。そして、上皮機能を提供する医療材料Sを所定期間、処置部30Aに留置した後に、樹脂部材822を尿道10内から抜去することで、本体部110が尿道10内から抜去される。この方法によれば、医療材料Sを処置部30Aに留置する際、樹脂部材822のみが尿道10の入口Eから処置部30Aに亘って留置されるため、留置中の体動に対して追従しやすく、より低侵襲に医療材料Sを処置部30Aに留置することができる。   Hereinafter, a procedure using the medical system according to Modification Example 8 will be described. Here, a procedure after the second push-out member 130 pushes the third tubular member 113 to the distal end side and the main body 110 is placed in a nested state will be described. The operator removes the second push-out member 130 from the moving part and removes it from the urethra 10. Then, after the medical material S that provides the epithelial function is placed in the treatment portion 30A for a predetermined period, the resin member 822 is removed from the urethra 10, whereby the main body 110 is removed from the urethra 10. According to this method, when the medical material S is placed in the treatment portion 30A, only the resin member 822 is placed from the entrance E of the urethra 10 to the treatment portion 30A, and therefore follows the body movement during placement. It is easy to place the medical material S in the treatment section 30A with less invasiveness.

1、3、4、5、6、7、8 医療システム、
10 尿道、
100、200 医療用処置具、
110 本体部、
111、211、311、411、511、611、711 第1管状部材(最内周管状部材)、
111A、211A 伸長部、
311A 第1磁性部(伸長部)、
411A、511A 係合部(伸長部)、
611A 拡張部(伸長部)、
711A 弾性部材(伸長部)、
112 第2管状部材、
113 第3管状部材(最外周管状部材)、
113C 移動部、
120、320、420、520、820 第1押出部材、
130 第2押出部材、
140 規制部、
S 上皮機能を提供する医療材料。
1, 3, 4, 5, 6, 7, 8 medical system,
10 urethra,
100, 200 medical treatment tool,
110 body,
111, 211, 311, 411, 511, 611, 711 First tubular member (innermost tubular member),
111A, 211A extension part,
311A 1st magnetic part (elongation part),
411A, 511A engagement portion (extension portion),
611A expansion part (extension part),
711A elastic member (extension part),
112 second tubular member,
113 third tubular member (outermost tubular member),
113C moving part,
120, 320, 420, 520, 820 first extruded member,
130 second extruded member,
140 Regulatory Department,
S Medical material that provides epithelial function.

Claims (9)

生体の体腔内に上皮機能を提供する医療材料を配置するための医療用処置具であって、
前記体腔内に挿通され、当該体腔内の長軸方向に伸縮可能とし、収縮状態において周方向に複数の層をなす本体部と、
前記本体部の最内層に設けられ、押出されることにより挿通方向の先端側に移動して前記本体部を伸長させるとともに、伸長状態において前記本体部の前記体腔内における位置を維持可能とする伸長部と、
外周に前記医療材料を配置可能な状態で前記本体部の最外層に設けられ、前記伸長部に沿って移動し前記本体部を収縮させる移動部と、を有する医療用処置具。
A medical treatment tool for placing a medical material providing an epithelial function in a body cavity of a living body,
A body portion that is inserted into the body cavity and is expandable and contractible in the longitudinal direction in the body cavity, and in a contracted state, forms a plurality of layers in the circumferential direction;
An extension that is provided in the innermost layer of the main body part and moves to the distal end side in the insertion direction by being pushed out to extend the main body part and maintain the position of the main body part in the body cavity in the extended state. And
A medical treatment instrument comprising: a moving part that is provided in an outermost layer of the main body part in a state where the medical material can be disposed on an outer periphery, and moves along the elongated part to contract the main body part.
前記本体部は、入れ子構造をなす複数の管状部材からなり、
前記伸長部は、複数の前記管状部材のうち最内周に位置する最内周管状部材に設けられ、前記管状部材を前記先端側に押し出す第1押出部材により押されて前記本体部を伸長させ、
前記移動部は、複数の前記管状部材のうち最外周に位置する最外周管状部材に設けられ、前記管状部材を前記先端側に押し出す第2押出部材により押されて前記本体部を収縮させる請求項1に記載の医療用処置具。
The main body portion is composed of a plurality of tubular members having a nested structure,
The extending portion is provided on the innermost peripheral tubular member located on the innermost periphery among the plurality of tubular members, and is extended by the first pushing member that pushes the tubular member toward the distal end side to extend the main body portion. ,
The said moving part is provided in the outermost peripheral tubular member located in the outermost periphery among several said tubular members, The said extrusion is pushed by the 2nd extrusion member which extrudes the said tubular member to the said front end side, The said main-body part is contracted. The medical treatment tool according to 1.
前記伸長部は、前記第1押出部材の先端部に突き当てられることによって押されて、前記本体部を伸長させる請求項2に記載の医療用処置具。   The medical treatment instrument according to claim 2, wherein the extension portion is pushed by being abutted against a distal end portion of the first push-out member to extend the main body portion. 前記伸長部は、前記第1押出部材と互いに係合する係合部を有する請求項2または請求項3に記載の医療用処置具。   The medical treatment instrument according to claim 2 or 3, wherein the extending portion includes an engaging portion that engages with the first push-out member. 前記伸長部は、前記最内層の内部に設けられ拡張変形可能な拡張部を有する請求項1〜4のいずれか1項に記載の医療用処置具。   The medical treatment instrument according to any one of claims 1 to 4, wherein the extension portion includes an extension portion that is provided inside the innermost layer and that can be extended and deformed. 前記移動部が、前記本体部を収縮させる際に、前記最内層が前記先端側に移動することを規制する規制部をさらに有する請求項1〜5のいずれか1項に記載の医療用処置具。   The medical treatment instrument according to any one of claims 1 to 5, further comprising a restricting portion that restricts movement of the innermost layer toward the distal end side when the moving portion contracts the main body portion. . 前記医療材料は、生体シートであって、
前記体腔は、尿道に形成された狭窄部である請求項1〜6のいずれか1項に記載の医療用処置具。
The medical material is a biological sheet,
The medical treatment tool according to any one of claims 1 to 6, wherein the body cavity is a narrowed portion formed in the urethra.
請求項1〜7のいずれか1項に記載の医療用処置具と、前記伸長部を前記先端側に押し出す第1押出部材と、前記移動部を前記先端側に押し出す第2押出部材と、を有する医療システム。   The medical treatment instrument according to any one of claims 1 to 7, a first pushing member that pushes the extending portion toward the distal end side, and a second pushing member that pushes the moving portion toward the distal end side. Having medical system. 前記第1押出部材は、内視鏡を有する請求項8に記載の医療システム。   The medical system according to claim 8, wherein the first push member has an endoscope.
JP2014201829A 2014-09-30 2014-09-30 Medical treatment instrument and medical system Pending JP2016067710A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014201829A JP2016067710A (en) 2014-09-30 2014-09-30 Medical treatment instrument and medical system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014201829A JP2016067710A (en) 2014-09-30 2014-09-30 Medical treatment instrument and medical system

Publications (1)

Publication Number Publication Date
JP2016067710A true JP2016067710A (en) 2016-05-09

Family

ID=55865342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014201829A Pending JP2016067710A (en) 2014-09-30 2014-09-30 Medical treatment instrument and medical system

Country Status (1)

Country Link
JP (1) JP2016067710A (en)

Similar Documents

Publication Publication Date Title
US10201689B1 (en) Urethral balloon dilator catheter
US7789893B2 (en) Method and apparatus for promoting hemostasis of a blood vessel puncture
JP4940390B2 (en) Medical device having knitted structure and coil
US8444671B2 (en) Hemostasis-enhancing device and method for its use
JP6533573B2 (en) Device having a j-shaped end and an inflatable balloon for use as a support for a device for tissue reconstruction of the resected tissue of the renal pelvis and / or the renal pelvic and ureteral junction
US10842918B2 (en) Length extensible implantable device and methods for making such devices
EP3206634B1 (en) Apparatus for delivering a device to a hollow organ
CN105307582A (en) Device for removing kidney stones
JP2018500980A (en) Internal iliac artery preservation device and method
US20230063969A1 (en) Flow control valve
JP2016154757A (en) Medical appliance, medical appliance assembly, balloon device, and treatment method for treating urinary tract constriction
AU2018201246B2 (en) Stent delivery system
JP2015144750A (en) Urethral stenosis therapeutic method
CN106806043A (en) Intraluminal stent and intraluminal stent system
JP2016067710A (en) Medical treatment instrument and medical system
CN115867207A (en) Medical delivery system and method of use
US9764119B2 (en) Urethral stricture treatment apparatus and urethral stricture treatment method
CN115427089A (en) Lumen sealing and methods of use
JPH05158U (en) Catheter tube
JP2023542530A (en) Delivery and evaluation aids for implants
CN115666670A (en) Medical treatment apparatus and associated methods
JP2015144751A (en) Urethral stenosis therapeutic method
JP2016185249A (en) Medical device and medical assembly
JP2016067677A (en) Indwelling device
JP2017012670A (en) Treatment instrument